The journal has adopted open access policy to all the published papers to ensure the maximum readership. All the articles published in IJARBN are made freely accessible online after publication in pdf format.
All the manuscripts submitted to IJARBN will be subjected to rigorous peer review process; The manuscript will be reviewed by three distinguished experts in respective subject area. The reports of all the reviewers will be taken into consideration while deciding on the acceptance/revision or rejection of a manuscript. Editor-In-Chief will make the final decision, based on reviewer’s comments.
All the articles published in IJARBN are distributed under a creative commons license. The journal allows the author(s) to hold the copyright of their work (all usages allowed except for commercial purpose).
International Journal of Advanced Research in Biotechnology & Nanobiotechnology follow the COPE Best Practice guidelines and this statement is based on the guidelines and standards developed by the Committee on Publication Ethics (COPE).
The Editor-in-chief (EIC) of International Journal of Advanced Research in Biotechnology & Nanobiotechnology is responsible to make the decision regarding publication of submitted articles. The EIC may be guided by the policies of the journal's editorial board and subjected to such legal requirements. The Editor is authorized to carry out the decision in consultation with reviewers and editorial board members.
Fair play: The manuscripts should be evaluated solely on their intellectual merit without regard to authors' race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy.
Confidentiality: The Editor and editorial staff must not disclose any information about a manuscript which is submitted to the journal to anyone other than the corresponding author, reviewers, other editorial advisors, and the publisher, as appropriate. The editor must ensure the integrity of double-blind peer-review and should not disclose the identity of the reviewers to the authors of that manuscript, and vice versa.
Disclosure and Conflict of interest: Unpublished materials disclosed in a submitted manuscript must not be used by editor or reviewer or anyone else who has a view of the manuscript, while handling it in his or her own research without the express written consent of the author.